GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: Enbezotinib was included in the WHO's list 126 of proposed INNs in January 2022. It was classified as a tyrosine kinase inhibitor and antineoplastic in that list. We drew the chemical structure from the INN document.
|
|
Bioactivity Comments |
As of 2nd Feb 2022 we have been unable to find further details (originator, molecular target, activity data) for this compound. |